Primary Hyperaldosteronism in a Male Patient: A Case Report

Area of Science:

• Endocrinology
• Cardiology
• Nephrology

Background:

• Hypertension is prevalent, with primary hypertension being the most common diagnosis.
• Secondary hypertension, often overlooked, requires specific screening protocols.
• Primary hyperaldosteronism (PA) is a significant, yet underdiagnosed, cause of secondary hypertension.

Observation:

• Sudden hypokalemia in hypertensive patients necessitates investigation for secondary causes.
• PA is frequently observed in younger individuals diagnosed with hypertension.
• PA is associated with increased risks of left ventricular hypertrophy, heart failure, and stroke compared to primary hypertension.

Findings:

• Primary hyperaldosteronism leads to more severe end-organ damage than primary hypertension.
• Patients with PA face higher rates of cardiovascular complications, including myocardial infarction and atrial fibrillation.
• The subtle presentation of PA contributes to its underdiagnosis by healthcare providers.

Implications:

• Increased awareness and screening for PA are vital in hypertensive populations.
• Timely diagnosis of PA can mitigate serious cardiovascular events and long-term health consequences.
• Further research into specific diagnostic markers and management strategies for PA is warranted.